Ivo Hrsak

Title: Ivo Hrsak: Innovator in Pharmaceutical Development

Introduction

Ivo Hrsak is a notable inventor based in Zagreb, Croatia. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compounds aimed at treating viral diseases and tumors. His work is characterized by a focus on adamantyl comprising tripeptides and their derivatives.

Latest Patents

Ivo Hrsak holds 2 patents related to his research. His latest patents include "New adamantyl comprising tripeptides, derivatives and hydrochlorides" and "Adamantyl comprising tripeptides, derivatives and hydrochlorides." These patents detail the compounds 2-Adamantyl- and 1-adamantyl-D/L-glycyl-L-alanyl-D-isoglutamine and their derivatives, which are particularly indicated for the treatment of viral diseases and tumors, as well as for immunomodulations in humans and animals.

Career Highlights

Ivo Hrsak is associated with Imunoloski Zavod, where he applies his expertise in pharmaceutical research and development. His innovative approach has led to advancements in the treatment options available for various medical conditions.

Collaborations

Ivo has collaborated with notable colleagues such as Jelka Tomasic and Branka Vranesic, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Ivo Hrsak's contributions to pharmaceutical innovation through his patents and collaborative efforts highlight his role as a key figure in the field. His work continues to impact the development of treatments for critical health issues.